Overview
Novo Holdings is a world-leading life science investor and the wholly owned holding and investment company of the Novo Nordisk Foundation. It focuses on generating long-term returns by investing across various life science segments, including pharmaceuticals, biotechnology, medical technology, and industrial biosolutions, at all stages of development, with a global geographic footprint.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.